The Sodium–Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model
Diabetes - United States
doi 10.2337/db16-0733
Full Text
Open PDFAbstract
Available in full text
Date
January 4, 2017
Authors
Publisher
American Diabetes Association